votoplam — FDA meeting
2H 2026
Plan to engage with FDA in 2H 2026 to discuss PIVOT-HD 24-month results being finalizedSource filing
PTCT biotech catalysts & pipeline
PTC THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
isaralgagene civaparvovec — Rolling NDA/BLA submission
Q4 2026
A rolling BLA submission to FDA for accelerated approval of ST-920 is expected to be completed in Q4 2026.Source filing
ST-920 — Rolling NDA/BLA submission
Q4 2026
A rolling BLA submission to FDA for accelerated approval of ST-920 is expected to be completed in Q4 2026.Source filing